Lacambra, M. G. (2024) “Renal Adverse Reaction Secondary to Check-point Inhibitors in Metastatic Renal Cancer”, Journal of Clinical Nephrology, 8(2), pp. 076–077. doi: 10.29328/journal.jcn.1001130.